Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
Abstract Background Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppressive mechanisms. Little is known about IDO activit...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2021-07-01
|
| Colección: | BMC Cardiovascular Disorders |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12872-021-02140-0 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
